Overview

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma

Status:
Recruiting
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of 3 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Carboplatin
Etoposide
Vincristine